Morgan Stanley analyst Sean Laaman assumed coverage of Denali Therapeutics (DNLI) with an Overweight rating and a price target of $33, down ...
Nevertheless, the new disappointment with DNL343 is another major disappointment to ALS patients, who have limited drug ...
The company is preparing to submit a Biologics License Application (BLA) for tividenofusp alfa, also known as DNL310, early this year, seeking accelerated approval. The U.S. Food and Drug ...
The company is preparing to submit a Biologics License Application (BLA) for tividenofusp alfa, also known as DNL310, early this year, seeking accelerated approval. The U.S. Food and Drug ...
New Alfa Romeo Stelvio SUV may be set to get petrol power after all New Alfa Romeo Stelvio SUV may be set to get petrol power after all Alfa’s large SUV is still on track, but the outgoing boss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback